Trump’s new Medicaid rules will kick in, and GOP states are tougher. Someone may be too frail to work but can’t afford to see a doctor to prove it

Medicaid work requirements will begin in January for up to 20 million expansion-enrolled adults, requiring 80 hours per month of work, volunteering or half-time schooling unless exempt. The 2025 law is projected by the Congressional Budget Office to save $887 billion over 10 years but leave 7.5 million fewer people insured. At least six Republican-led states will require immediate medical documentation for frailty exemptions rather than allowing initial self-attestation, raising risks of procedural coverage losses and added state technology costs.

Analysis

The investable transmission is not simply lower Medicaid enrollment; it is adverse selection and uncompensated-care migration. Medicaid MCOs with concentrated expansion exposure—especially MOH and CNC—could see membership pressure, while remaining members skew higher acuity as healthier, intermittently employed beneficiaries churn off. Rate-setting often lags that acuity shift by one or more budget cycles, creating a 1-3 quarter medical-cost-ratio risk even where headline capitation revenue declines are partly offset by lower utilization.

For providers, the more material exposure is concentrated in hospitals and behavioral-health systems serving low-income populations. THC, CYH and UHS have greater downside sensitivity than HCA to elevated self-pay volumes, collection-cost increases and pressure on state-directed/supplemental payments; the latter may cushion reported revenue but are politically and fiscally less durable than insured reimbursement. The first-order enrollment effect should emerge over 3-12 months, but bad-debt and payer-mix deterioration normally surface with a lag in quarterly results.

A less appreciated offset is implementation spending. Eligibility-system modernization, data matching and call-center workloads can support state-services vendors, but this is not yet a clean public-equity trade because contract awards, funding sources and vendor allocation remain unspecified. Litigation and administrative incapacity are the key near-term reversals: injunctions, CMS implementation flexibility, or states adopting less restrictive verification would reduce the enrollment shock; conversely, large procedural-disenrollment rates would make current provider and MCO estimates vulnerable.

Key Decisions for Investors

• Establish a 6-12 month defensive payer-mix pair: long HCA / short THC, sized dollar-neutral. HCA's commercial mix and scale should better absorb uninsured-volume migration than THC; target a 10-15% relative return, with thesis invalidated if THC demonstrates stable self-pay collections and Medicaid/supplemental-payment guidance through two reporting periods.
• Put MOH and CNC on a quarterly watch for Medicaid membership declines, acuity trends and state rate adequacy rather than shorting immediately. Initiate a tactical short only if expansion-plan membership falls faster than management guidance while MLR guidance is maintained or raised; cover on evidence that states rebase rates promptly or enrollment losses are concentrated in high-cost cohorts.
• Underweight CYH and UHS versus HCA over the next 2-4 quarters where portfolios require hospital exposure. The trade should be reduced if state supplemental-payment commitments rise enough to offset bad-debt provisions, or if unemployment-driven enrollment growth reverses the expected churn.
• Monitor MAXIMUS (MMS) and Conduent (CNDT) for disclosed state eligibility, verification or contact-center awards; treat contract wins as a 12-24 month revenue alert, not a preemptive long. Required diligence is contract value, margin structure, implementation timing and whether work is funded from incremental state appropriations.
• Track state court rulings, CMS enforcement guidance and monthly Medicaid enrollment data beginning with the first implementation cohorts. A broad injunction or documented adoption of provisional exemptions would invalidate the near-term provider/MCO dislocation thesis and argue for closing relative-value positions.